Lv1
50 积分 2024-07-16 加入
Management of familial adenomatous polyposis and MUTYH-associated polyposis; new insights
4小时前
已完结
First-line cemiplimab monotherapy and continued cemiplimab beyond progression plus chemotherapy for advanced non-small-cell lung cancer with PD-L1 50% or more (EMPOWER-Lung 1): 35-month follow-up from a mutlicentre, open-label, randomised, phase 3 trial
1个月前
已完结
Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma
7个月前
已完结
CAR-T cell combination therapies in hematologic malignancies
7个月前
已完结
Characterization of second primary malignancies post CAR T-cell therapy: real-world insights from the two global pharmacovigilance databases of FAERS and VigiBase
7个月前
已完结
New Biological Therapies for Multiple Myeloma
7个月前
已完结
皖公网安备34019202002308
